The operation described below was likewise based on the concept that an "outflow block" is one of the major physiologic disorders in cirrhotic ascites, and entails both the treatment of ascites by ...

Treatment of ascites is initially based on diuretics, but randomized studies assessing the efficacy of different combinations of diuretics are very scarce. Angeli et al. compared the efficacy and ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

Not all patients with ascites respond to spironolactone, which is the standard treatment for this condition. However, the multinational HypoCAT study has found that satavaptan, a selective ...

Catumaxomab Received a Positive Opinion From the EMA's Committee for Medicinal Products for Human Use (CHMP) at Its October 2024 Meeting and If ...

Treatment can be a little complex but focuses on reducing fluid retention and improving your overall quality of life. The ...

Lindis Biotech has licensed Korjuny (catumaxomab) to Pharmanovia for malignant ascites, offering a targeted immune therapy ...

In contrast to LVP, which provides only symptomatic control and requires repeated procedures, TIPS efficiently prevents the formation of ascites and increases urinary sodium excretion by reducing ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...

Keep abreast with the latest news related to Ascites there are 14 news items on Ascites that covers updates, breakthroughs and in-depth reports. We provide you with a free downloadable secure ...

(BUSINESS WIRE )--Pharmanovia, a global Pharmaceutical company that commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines, has today announced the ...